Co-dosed compounds stability effect [Regulatives / Guidelines]

posted by jchapdelaine – 2010-11-17 20:54 (5703 d 07:56 ago) – Posting: # 6159
Views: 3,616

Hi Marko,

I do have a bit more information on this subject as I spoke to the FDA a few months ago concerning this at the BSAT-APA conference.

❝ Is there indeed a full validation needed in such cases?


There is no stated requirement for a full validation, however it is not sufficient to demonstrate lack of interference. The stability of the quantitated analytes must also be re-evaluated.

FDA is also looking to provide more information on this at upcoming conferences.

Regards,
John

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
214 visitors (0 registered, 214 guests [including 40 identified bots]).
Forum time: 05:51 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5